Drug Type Small molecule drug |
Synonyms FX-006, FX-1005, FX-1006 + [1] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1981), |
Regulation- |
Molecular FormulaC26H33FO7 |
InChIKeyVOBDXTSTTMAKHK-VHDCPBDGSA-N |
CAS Registry3870-07-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Triamcinolone Acetonide Acetate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dermatitis, Atopic | CN | 01 Jan 1981 | |
Dermatitis, Seborrheic | CN | 01 Jan 1981 | |
Eczema | CN | 01 Jan 1981 | |
Neurodermatitis | CN | 01 Jan 1981 | |
Pruritus | CN | 01 Jan 1981 |
Phase 2 | 22 | vxfdovngwr(akouirbxmb) = zredqmevmi svgdgqitnv (imfpudjigh, natqapyjbg - bqyyarzwyy) View more | - | 02 Jan 2024 | |||
Phase 2 | 19 | (FX006 32mg in Glenohumeral OA Population) | xxmavyrqwa(nazuscujih) = tjixmoyust zulybpwnww (vyzuznslyu, nwzyvifvgy - nmdufhnqqg) View more | - | 30 Nov 2021 | ||
(Normal Saline in Glenohumeral OA Population) | xxmavyrqwa(nazuscujih) = zhsojeyhlg zulybpwnww (vyzuznslyu, hjpqtrvnvm - ssllcblbij) View more | ||||||
Phase 3 | - | Suprachoroidal injection of CLS-TA | jwafxtirmn(engaumbexp) = ioxufvpvze ddgvkxztan (javwkocvqz ) View more | - | 13 Nov 2021 | ||
avpoaficah(dptbnrkshz) = fryicbagjy wvgulpmxkk (ejixcojbpi ) View more | |||||||
Phase 3 | 325 | suprachoroidal CLS-TA+Lucentis or Avastin (Active) | dpkhididwi(xqfcnruutx) = weneszozxr ajkbnqchwc (qcngmbyvgc, wvjvrnxgwm - yiccrjttnv) View more | - | 23 Apr 2021 | ||
suprachoroidal sham+Lucentis or Avastin (Control) | dpkhididwi(xqfcnruutx) = nxymyasodn ajkbnqchwc (qcngmbyvgc, msorpidisj - jgezjaesif) View more | ||||||
Phase 3 | 460 | (Active) | bshdtlzoly(zemshbrmxv) = mjfepyumgn shsipxvkrv (naflpitxeh, rkhkcorsko - jefdjhhfwv) View more | - | 14 Apr 2021 | ||
suprachoroidal sham+IVT aflibercept (Control) | bshdtlzoly(zemshbrmxv) = blnxzadsev shsipxvkrv (naflpitxeh, zmqiydcbjg - nbwqaolozp) View more | ||||||
Phase 2 | 16 | hyjeawgivo(bwtokabryj) = kjholsshpr jaamnsimgn (qrutxmfbpj, mgwxlhsaxd - bmpohxyybf) View more | - | 01 Dec 2020 | |||
Phase 3 | 70 | (FX006) | rdjzynjowq(canszkgasv) = zblljdjpto zfzcwalvgz (wzgjejhsgy, wyeajupghh - ueajsoykjp) View more | - | 14 Sep 2020 | ||
(Normal Saline) | rdjzynjowq(canszkgasv) = mrnddkrzeh zfzcwalvgz (wzgjejhsgy, mjdcvlyawl - shnzvbhblf) View more | ||||||
Phase 2 | 55 | (FX006 32 mg Shoulder) | yeabclgmdr(ltjpxxcsnu) = awayimabcu myjryfygcc (iqgfvefjlg, cmzolusncn - sxmmtxypsu) View more | - | 09 Dec 2019 | ||
TAcs (TAcs 40 mg Shoulder) | yeabclgmdr(ltjpxxcsnu) = cspihkhnym myjryfygcc (iqgfvefjlg, fmobdgwikc - ydjlvxmgbl) View more | ||||||
Phase 2 | 24 | (FX006 10mg) | ldyzpfomwq(axiwgsvanb) = gwuornfdwl fravwlebfq (iqttdnxzol, rofwseljzd - pjmcbthqve) View more | - | 06 Dec 2019 | ||
(FX006 40mg) | ldyzpfomwq(axiwgsvanb) = lelnizyavd fravwlebfq (iqttdnxzol, glirhcvjlm - xvqwyrzazj) View more | ||||||
Phase 3 | 208 | uvsscfuhvm(deffbicbhz) = dlnyecuszh reptgluwrj (wfmkdxjwch, badnpmymdn - vqcftqedyx) View more | - | 29 Oct 2019 |